Renaissance Technologies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-530,200
| Closed | -$8.34M | – | 4078 |
|
|
2024
Q1 | $8.34M | Buy |
530,200
+92,900
| +21% | +$1.46M | 0.01% | 1095 |
|
|
2023
Q4 | $7.05M | Buy |
437,300
+125,900
| +40% | +$2.03M | 0.01% | 1130 |
|
|
2023
Q3 | $3.96M | Buy |
311,400
+190,800
| +158% | +$2.43M | 0.01% | 1434 |
|
|
2023
Q2 | $1.7M | Sell |
120,600
-110,718
| -48% | -$1.56M | ﹤0.01% | 2100 |
|
|
2023
Q1 | $3.57M | Buy |
231,318
+140,618
| +155% | +$2.17M | ﹤0.01% | 1677 |
|
|
2022
Q4 | $1.49M | Buy |
+90,700
| New | +$1.49M | ﹤0.01% | 2270 |
|
|
2022
Q3 | – | Sell |
-88,900
| Closed | -$1.17M | – | 4511 |
|
|
2022
Q2 | $1.17M | Buy |
+88,900
| New | +$1.17M | ﹤0.01% | 2605 |
|
|
2021
Q4 | – | Sell |
-34,800
| Closed | -$1.18M | – | 4301 |
|
|
2021
Q3 | $1.18M | Buy |
+34,800
| New | +$1.18M | ﹤0.01% | 2457 |
|
|
2020
Q2 | – | Sell |
-418,600
| Closed | -$17.2M | – | 3836 |
|
|
2020
Q1 | $17.2M | Buy |
418,600
+204,000
| +95% | +$8.4M | 0.02% | 853 |
|
|
2019
Q4 | $13.4M | Buy |
214,600
+70,900
| +49% | +$4.41M | 0.01% | 1261 |
|
|
2019
Q3 | $4.88M | Buy |
+143,700
| New | +$4.88M | ﹤0.01% | 1811 |
|